Plunkett Research Online: Aviragen Therapeutics Inc

AVIRAGEN THERAPEUTICS INC (AVIR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., formed from the merging of Nabi Biopharmaceuticals and Biota Holdings Ltd., is a development-level biopharmaceutical company that focuses on vaccines and therapies for the treatment and prevention of infectious diseases. The firm is.....



Aviragen Therapeutics Inc
Ticker: AVIR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 678-221-3343
Fax:
Address: 2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Infectious Disease & Autoimmune Disorders
Vaccines
Addiction Treatments
ContactsDescription
Mark ColonneseCFO/Chief Accounting Officer/Executive VP
Russell PlumbChairman of the Board/Director
See More
Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., formed from the merging of Nabi Biopharmaceuticals and Biota Holdings Ltd., is a development-level biopharmaceutical company that focuses on vaccines and therapies for the treatment and prevention of infectious diseases. The firm is.....See More See More

Auditor: Ernst & Young LLP.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Biota Pharmaceuticals Inc
Nabi Biopharmaceuticals
Biota Holdings Ltd
Vapendavir
BTA585
BTA074
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: